Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Swallowed Flovent in Eosinophilic Esophagitis
NCT00266578Phase 3Completed
- Start
- Oct 2002
- Primary completion
- Nov 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in eosinophilic esophagitis (EoE) comparing Flovent with Placebo (2 arms). Primary endpoint: Histologic remission at 5 years. Started Oct 2002; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT00266578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266578.